Skip to content

Electrical Muscle Stimulation and Strength Training in people with Inflammatory Muscle Diseases: an initial study

Neuromuscular Electrical Stimulation combined with Resistance Exercise in patients with Inflammatory Myopathies: A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5ppzpv3
Enrollment
10
Registered
2026-07-14
Start date
2026-10-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polymyositis Dermatomyositis

Interventions

This is a single-arm, non-randomized, uncontrolled, unblinded clinical study. Experimental group (single group): Ten individuals with inflammatory myopathy will undergo 24 sessions of resistance exerc

Sponsors

Universidade Estadual de Campinas
Lead Sponsor
Universidade Estadual de Campinas
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Volunteers with a diagnosis of idiopathic inflammatory myopathy; aged eighteen years or older; of either sex; complete clinical response to their current treatment

Exclusion criteria

Exclusion criteria: New York Heart Association functional classes three or four heart failure; any sustained ventricular arrhythmia or atrial arrhythmia with uncontrolled heart rate; interstitial lung disease with symptoms corresponding to a modified Medical Research Council dyspnea score greater than two; active systemic infections; muscle weakness of neurological origin; joint limitations that preclude exercise performance; pregnancy; severe cognitive impairment that compromises the safe use of the neurostimulator; use of anabolic steroids within the previous three months; use of creatine within the previous four weeks; and current participation in an exercise program involving more than a hundred and fifty minutes per week of physical activity of at least moderate intensity

Design outcomes

Primary

MeasureTime frame
Good safety of the protocol is expected, as assessed by the number of adverse events classified according to the Common Terminology Criteria for Adverse Events (CTCAE), defined by the occurrence of fewer than 50% of participants experiencing mild or moderate adverse events and the absence of any severe adverse events

Secondary

MeasureTime frame
Good adherence to the protocol is expected, as assessed by the proportion of attended sessions relative to the total number of planned sessions, defined as an attendance rate of at least 75%;An increase in peak isometric strength, measured by dynamometry, is expected, as evidenced by a statistically significant improvement between the pre- and post-intervention assessments;An increase in walking distance, measured by the 6-minute walk test, is expected, as evidenced by a statistically significant improvement between the pre- and post-intervention assessments;An increase in the number of repetitions during a functional exercise, measured by the 30-second sit-to-stand test, is expected, as evidenced by a statistically significant improvement between the pre- and post-intervention assessments;An increase in quadriceps muscle volume, measured by the cross-sectional area obtained by ultrasound, is expected, as evidenced by a statistically significant improvement between the pre- and post-intervention assessments

Countries

BR

Contacts

Public ContactJean De Souza

Universidade Estadual de Campinas

souzajm@unicamp.br+55(19)3521-9211

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026